Microfractionation bioactivity-based ultra performance liquid chromatography/quadrupole time-of-flight mass spectrometry for the identification of nuclear factor-κB inhibitors and β2 adrenergic receptor agonists in an alkaloidal extract of the folk herb Alstonia scholaris.

[1]  Gang Bai,et al.  Bioactivity-based liquid chromatography-coupled electrospray ionization tandem ion trap/time of flight mass spectrometry for β₂AR agonist identification in alkaloidal extract of Alstonia scholaris. , 2012, Journal of chromatography. A.

[2]  K. Chibale,et al.  Identification and characterization of reactive metabolites in natural products-driven drug discovery. , 2012, Journal of natural products.

[3]  Asher Mullard,et al.  2011 FDA drug approvals , 2012, Nature Reviews Drug Discovery.

[4]  Peng Tian,et al.  Convergence: Where West meets East , 2011, Nature.

[5]  Guangji Wang,et al.  Recent Development in Liquid Chromatography/Mass Spectrometry and Allied Topics for Traditional Chinese Medicine Research , 2011 .

[6]  M. Ganzera,et al.  Recent advances on HPLC/MS in medicinal plant analysis. , 2011, Journal of pharmaceutical and biomedical analysis.

[7]  L. Neuville,et al.  Protecting-group-free total synthesis of (E)- and (Z)-alstoscholarine. , 2011, Angewandte Chemie.

[8]  Tao Feng,et al.  Pharmacological evaluation of Alstonia scholaris: anti-tussive, anti-asthmatic and expectorant activities. , 2010, Journal of ethnopharmacology.

[9]  Luyong Zhang,et al.  Pharmacological evaluation of Alstonia scholaris: anti-inflammatory and analgesic effects. , 2010, Journal of ethnopharmacology.

[10]  Anand A. Dalal,et al.  The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management. , 2010, Primary care respiratory journal : journal of the General Practice Airways Group.

[11]  Ashutosh Kumar Singh,et al.  A new indole alkaloid from Alstonia scholaris , 2009, Natural product research.

[12]  Lian‐Wen Qi,et al.  Herbal medicine analysis by liquid chromatography/time-of-flight mass spectrometry. , 2009, Journal of chromatography. A.

[13]  R. Clark Prospective ligand- and target-based 3D QSAR: state of the art 2008. , 2009, Current topics in medicinal chemistry.

[14]  Min Yang,et al.  Phytochemical analysis of traditional Chinese medicine using liquid chromatography coupled with mass spectrometry. , 2009, Journal of chromatography. A.

[15]  Bethan Hughes,et al.  2008 FDA drug approvals , 2009, Nature Reviews Drug Discovery.

[16]  Gang Bai,et al.  Identification of higenamine in Radix Aconiti Lateralis Preparata as a beta2-adrenergic receptor agonist , 2008, Acta Pharmacologica Sinica.

[17]  S. Giordano,et al.  From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. , 2008, Current medicinal chemistry.

[18]  A. Viola,et al.  Chemokines and their receptors: drug targets in immunity and inflammation. , 2008, Annual review of pharmacology and toxicology.

[19]  X. Long,et al.  Role of NF-κB in TNF-α-induced COX-2 Expression in Synovial Fibroblasts from Human TMJ , 2007 .

[20]  P. Ashok,et al.  Antinociceptive and Anti-inflammatory Activities of Alstonia scholaris Linn. R.br , 2007 .

[21]  Xiao-Dong Luo,et al.  Unique monoterpenoid indole alkaloids from Alstonia scholaris. , 2007, Organic letters.

[22]  L. O’Neill,et al.  Targeting signal transduction as a strategy to treat inflammatory diseases , 2006, Nature Reviews Drug Discovery.

[23]  P. Barnes Drugs for asthma , 2006, Treatment guidelines from the Medical Letter.

[24]  P. Proost,et al.  Synergy in cytokine and chemokine networks amplifies the inflammatory response. , 2005, Cytokine & growth factor reviews.

[25]  R. Witkamp,et al.  Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology , 2005, Phytotherapy research : PTR.

[26]  Péter Csermely,et al.  The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.

[27]  M. R. Khan,et al.  Antibacterial activity of Alstonia scholaris and Leea tetramera. , 2003, Fitoterapia.

[28]  J. Pelletier,et al.  Cyclooxygenase-2 and prostaglandins in articular tissues. , 2003, Seminars in arthritis and rheumatism.

[29]  G. Chiappara,et al.  Cellular network in airways inflammation and remodelling. , 2002, Paediatric respiratory reviews.

[30]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[31]  A. B. Kay,et al.  Asthma and inflammation. , 1991, The Journal of allergy and clinical immunology.

[32]  Ying Zhang,et al.  Development of liquid chromatography/mass spectrometry methods for the quantitative analysis of herbal medicine in biological fluids: a review. , 2010, Biomedical chromatography : BMC.

[33]  C. Hai Airway smooth muscle cell as therapeutic target of inflammation. , 2007, Current medicinal chemistry.

[34]  B. Stockwell,et al.  Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.

[35]  D J Newman,et al.  The influence of natural products upon drug discovery. , 2000, Natural product reports.

[36]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.